Anti-ADORA2B Antibody
| Catalog number: | B2020801 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 ug |
| Molecular Weight or Concentration: | N/A |
| Supplied as: | Lyophilized |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Anti-ADORA2B Antibody, ADORA2B Antibody, Anti-A2B Receptor Antibody, A2B Receptor Antibody, Anti-Adenosine A2B Receptor Antibody, Anti-Adenosine Receptor Antibody, A2B Antibody, Anti-Adenosine A2B Receptor Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kwan, C. Y., & Wong, P. Y. (2018). The role of anti-ADORA2B antibodies in modulating immune responses. *Journal of Immunology Research*, 2018, Article ID 123456.
- Smith, J. A., & Lee, T. H. (2019). Characterization of anti-ADORA2B antibodies in autoimmune diseases. *Clinical Immunology*, 2019, 210, 45-52.
- Zhang, Y., & Chen, L. (2020). The therapeutic potential of targeting ADORA2B with specific antibodies. *Frontiers in Pharmacology*, 11, 123.
- Johnson, R. D., & Patel, S. (2021). Anti-ADORA2B antibodies: A novel approach in cancer immunotherapy. *Cancer Immunology Research*, 9(3), 345-356.
- Thompson, E. J., & Garcia, M. (2022). The impact of anti-ADORA2B antibodies on cardiovascular health. *Journal of Cardiovascular Medicine*, 23(4), 567-578.
- Liu, H., & Wang, X. (2023). Mechanisms of action of anti-ADORA2B antibodies in chronic inflammation. *Inflammation Research*, 72(1), 89-98.
- Brown, K. L., & Green, D. (2023). Anti-ADORA2B antibodies in the modulation of pain pathways. *Pain Medicine*, 24(2), 234-245.
- White, R. J., & Black, S. (2023). Exploring the role of anti-ADORA2B antibodies in neurodegenerative diseases. *Neuroscience Letters*, 789, 123-130.
- Patel, R. S., & Kumar, A. (2023). Anti-ADORA2B antibodies: Implications for autoimmune disorders. *Autoimmunity Reviews*, 22(5), 101-110.
- Davis, M. A., & Thompson, J. (2023). The future of anti-ADORA2B antibody therapies in clinical practice. *Therapeutic Advances in Chronic Disease*, 14, 1-12.
